Christopher L. Carpenter - Net Worth and Insider Trading
Christopher L. Carpenter Net Worth
The estimated net worth of Christopher L. Carpenter is at least $1,986 dollars as of 2024-11-13. Christopher L. Carpenter is the Chief Medical Officer of Rubius Therapeutics Inc and owns about 34,843 shares of Rubius Therapeutics Inc (RUBY) stock worth over $1,986. Details can be seen in Christopher L. Carpenter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher L. Carpenter has not made any transactions after 2019-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher L. Carpenter
Christopher L. Carpenter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher L. Carpenter owns 1 companies in total, including Rubius Therapeutics Inc (RUBY) .
Click here to see the complete history of Christopher L. Carpenter’s form 4 insider trades.
Insider Ownership Summary of Christopher L. Carpenter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2019-12-16 | Chief Medical Officer |
Christopher L. Carpenter Latest Holdings Summary
Christopher L. Carpenter currently owns a total of 1 stock. Christopher L. Carpenter owns 34,843 shares of Rubius Therapeutics Inc (RUBY) as of December 16, 2019, with a value of $1,986.
Latest Holdings of Christopher L. Carpenter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2019-12-16 | 34,843 | 0.06 | 1,986 |
Holding Weightings of Christopher L. Carpenter
Christopher L. Carpenter Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher L. Carpenter has made a total of 1 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 48,000 shares on December 16, 2019, which brought Christopher L. Carpenter around $647,040.
Insider Trading History of Christopher L. Carpenter
- 1
Christopher L. Carpenter Trading Performance
Christopher L. Carpenter Ownership Network
Ownership Network List of Christopher L. Carpenter
Ownership Network Relation of Christopher L. Carpenter
Christopher L. Carpenter Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Christopher L. Carpenter is the Chief Medical Officer of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Christopher L. Carpenter Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher L. Carpenter. You might contact Christopher L. Carpenter via mailing address: C/o Rubius Therapeutics, 325 Vassar St., Suite 1a, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
